classificazione e anamnesi |
diagnosi | uveiti anteriori | uveiti intermedie | uveiti posteriori | panuveiti | uveiti infantili | sindromi masquerade | bibliografia |
BIBLIOFRAFIA
[1] Sandler G. The importance of the history in the medical and the cost of the
unnecessary tests. Am Heart J. Dec. 1980; 100(6PT): 928-31
[2] Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis
nomenclature for reporting clinical data. Results of the First International
Workshop. Am J Ophthamol. Sep 2005; 140(3): 509-16.
[3] Chatzistefanou K, Markomichelakis NN, Christen W, Sohelian M, Foster CS.
Characteristics of uveitis presenting for the first time in the elderly.
Ophthalmology 1998; 105: 347-52.
[4] Benezra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J
Ophthalmol 2005; 89: 444-8.
[5] Smith RE, Nozik RA. Uveitis. In: A Clinical Approach to Diagnosis and
Management. 3° ed. Lippincott Williams & Wilkins; 2003.
[6] Rosenbaum JT, Wernick R. The utility of routine screening of patient with
uveitis for systemic lupus erythematosus or tubercolosis. A Bayesian analysis.
Arch Ophthamol. Sep 1990; 108(9): 1291-3.
[7] Sackett DL, Richardson WS, Rosenberg W, Haynes B. Evidence-based medicine.
In: How to practice and Teach EBM. Ed. Harcourt Health Sciences; 1996
[8] Intraocular inflammation and uveitis, Basic and clinical science course,
2003-2004, American Academy of Ophthalmology, 2003, p. 92.
[9] Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity
and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol.2006;
90: 103.
[10] Wilson D; Rheumatoid factors in patients with rheumatoid arthritis. Can Fam
Physician. 2006 Feb; 52: 180-1.
[11] Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for
clinical use of the antinuclear test ant tests for specific autoantibodies to
nuclear antigens. American College of pathologists. Arch pathol Lab Med 2000;
124: 71-81.
[12] Mori T, Sakatani M, Yamagishi F, Takashima T. Specific detection of
tubercolosis infection: an Interferon-γ-based assay using new antigens. Am J.
Resp. Crit. Care Med. 170: 59-64.
[13] Felberg NT, Shileds JA, Fiderman JL. Antibody to Toxocara canis in th
aqueous humor. Arch. Ophthalmol. 1981; 1563-1564
[14] Anderson S, Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and
practice of infectious diseases. New York, John Wiley; 1979.
[15] Herbort CP, Borruat FX, De Courten C, Jaccard L. Angiographie au vert d’indocyanine
dans les uveites posterieures. Klin Monatsbl Augenheilkd 1996; 208: 321-6.
[16] Herbort CP, MD. Schematic interpretation of Indocyanine Green Angiography
in posterior uveitis using a standard angiographic protocol. Ophthalmology Sep
1998; 105: 432-440.
[17] Tran VT, Mermoud A, Herbort CP. Appraisal and management of ocular hypotony
and glaucoma associated with uveitis. Int Ophthalmol Clin 2000; 40: 175-203.
[18] Sith Rl, Baarsma GS. Epidemiology of uveitis. Current opinion in
ophthalmology. Jun 1995; 6(3): 57-61.
[19] McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes
of uveitis in the general practice of ophthalmology. UCLA Community-Based
Uveitis Study Group. Am J Ophthalmol 1996; 121: 35-46.
[20] Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis.
Am J Ophthamol. 1987; 103: 131-6.
[21] Rodriguez A, Calonge M Pedroza-Seres M, Akova YA, Messmer EM, D’Amico DJ,
et al. Referral patterns of uveitis in a tertiary eye care center. Arch
Ophthalmo. May 1996; 114(5):593-9.
[22] Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northen
California. The Northen California epidemiology of Uveitis Study. Ophthalmology.
Mar 2004; 111(3): 491-500.
[23] Becker MD, Zierhut. Fuchs uveitis syndrome is no “condition sine qua non”.
Ophthalmologe. 2005 Jul; 102(7): 733-42.
[24] Mercanti B, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L. Epidemiology of
endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta
Ophthalmol Scand 2001; 79: 64-8.
[25] Salu P, Stemples N, Vanden Houte K, Verbeelen D. Acute tubulointerstitial
nephritis and uveitis syndrome in the elderly. Br J Ophthalmol 1990; 74:53.
[26] Salvarani C, Boiardi L, Mantovani V, et al. Association of MICA alleles and
HLA B51 in Italian patients with Behçet disease. J Rheumatology. 2001 Aug;
28(8): 1867-70.
[27] Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition treatment and
prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology.
May 2007; 114(5): 995-9.
[28] Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group
recommendations for the evaluation of intraocular inflammation. American J
Ophthalmol. 1987; 103: 234-235.
[29] Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis.
Am J Ophthalmol. Feb 15 1987; 103(2): 131-6.
[30] Shields JA. Ocular Toxocariasis. A rewiew. Surv. Ophthalmol. 1984: 28:
361-381
[31] Knox DL, Bayless TM, Yardley JH, Charance P. Whipple’s disease presenting
with ocular inflammation and minimal intestinal symptoms. John Hopkins Med J.
1968; 123: 175-82.
[32] Pflugfelder SC, Flynn HW, Zwickey TA, et al: Exogenous fungal
endophthalmitis. Ophthalmology 95: 19-30, 1998.
[33] Brown DH: Ocular toxocara canis. II Clinical review. J Pediatr Ophthalmol
7: 182-191, 1970.
[34] Sharkey JA, McKay PS. Ocular toxocariasis in a patient with repeatedly
negative ELISA titers to Toxocara canis. Br J Ophthalmol 1993; 77: 253-254.
[35] Margolis TP, Lowder CY, Holland GN, et al: Varicella-zoster virus retinitis
in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 112:
119-131, 1991.
[36] Nashi M, Hanashiro R, Mori S, et al: Polymerase chain reaction for the
detection of the varicella-zoster genome in ocular samples from patients with
acute retinal necrosis. Am J Ophthalmol 114; 603-609, 1992.
[37] Sison Rf, Holland GN, MacArthur LJ et al. Cytomegalovirus retinopathy as
the initial manifestation of the acquired immunodeficiency syndrome. Am J
Ophthalmol 1991; 112: 243-249.
[38] Obenauf CD, Shaw HE, Syndor CF, Klintworth GK: Sarcoidosis and its
ophthalmic manifestations. Am J Ophthalmol 86: 648-655, 1978.
[39] Wolfensberger TJ, Piguet B, Herbort CP. Indocyanine green angiographic
features in tubercolosis chorioretinitis. Am J Ophthalmology 1999; 127: 350-353.
[40] Feltkamp TEW. Ophthalmological significance of HLA-associated uveitis. Eye
1990; 4: 839-884.
[41] Dhaliwal RS, Maguire AM, Flower RW et al. Acute posterior multifocal
placoid pigment epitheliopathy. An indocyanine green angiographic study. Retina
1993; 13: 317-325.
[42] Stanga PE, Lim JI, Hamilton P. Indocianin green angiography in
chorioretinal diseases: indication and interpretation: an evidence-based update.
Ophthalmology 2003; 110: 15-21.
[43] Deutman AF, Oosterhius JA, Boen-Tan TN, et al: Acute posterior multifocal
placoid pigment epiteliopathy: pigment epiteliopathy or coriocapillaritis. Br J
Ophthalmol 56: 863-874, 1972.
[44] Fish RH, Hoskins JC. Toxoplasma neuroretinitis. Ophthalmology, 1992; 100:
480-486.
[45] Fish RH, Weingeist TA. Syphilitic neuroretinitis. American J Ophthalmol
1983; 95: 480-486.
[46] Renie WA, Murphy RP, Anderson KC et al: The evaluation of patients with
Eales’disease. Retina 1983; 3: 243-248.
[47] Watanabe Y, Takeda N, Adachi-Usami E: A case of frosted branch angiitis. Br
J Ophthalmol 1987; 71: 553-558.
[48] Henderly DE, Genstler AJ, Smith RE, Rao NA: Changing patterns of uveitis.
Am J Ophthalmol 1987; 103: 131-136.
[49] Cunnigham ET. Uveitis in children. Ocul Immunol Immunopath 2000; 8:
251-261.
[50] Kotaniemi K, Arkela-Kautiainen, Haapasaari J, Leirisalo-Repo M. Uveitis in
young adults with juvenile idiopathic arthritis: a clinical evaluation of 123
patients. Ann Rheum Dis 2005; 64: 871-874.
[51] Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A
population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp
Rhematol. 1999;17:119-122.
[52] Read RW, Zamir E, Rao NA: Neoplastic masquerade syndrome. Surv Ophthalmol
2002;47:81-124.
[53] Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Int Med
1993; 119; 1093-104.